Inovio Pharmaceuticals Inc (INO)
Healthcare
Biotechnology
0.70 $
+2.9%
vs. previous close
Closing price · As of: 3. Aug 2026
Who owns Inovio Pharmaceuticals Inc (INO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.5% of the shares are freely tradable; institutional investors hold 47.3%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
47.3%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
0.4%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
99.5%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
20.2%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
82Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| FMR Inc | 11.35 | 9,339,614 | -5.1 | 03/31/2026 |
| HHG PLC | 4.02 | 3,308,406 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.53 | 2,901,208 | +0.0 | 03/31/2026 |
| Boxer Capital Management, LLC | 2.88 | 2,370,122 | -2.1 | 03/31/2026 |
| D. E. Shaw & Co LP | 2.69 | 2,212,819 | -0.9 | 03/31/2026 |
| ADAR1 Capital Management LLC | 1.79 | 1,470,108 | -1.0 | 03/31/2026 |
| Millennium Management LLC | 1.71 | 1,410,845 | +0.5 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Fidelity Small Cap Growth | 6.85 | 5,632,660 | +0.0 | 05/31/2026 |
| Fidelity Small Cap Growth K6 | 3.43 | 2,822,120 | +0.0 | 05/31/2026 |
| Vanguard Morn Total Stk Mkt Idx Investor | 3.16 | 2,600,092 | +0.0 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.